CVS break-up shows how M&A-first strategy is not the healthiest option

翻译尚未完成，当前显示原文。

Despite touting better customer outcomes as well as major financial benefits, its stock price has underperformed

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。